Working Session + Roadmap
Data Strategy & Monetization
A facilitated strategy engagement that inventories your data assets, pressure-tests their commercial potential, and delivers a sequenced monetization roadmap, from near-term revenue like clinical trials support to a long-term de-identified data asset.
Book a CallThe Problem
“You're sitting on valuable data, but every monetization conversation stalls: too many stakeholders, no clear owner, no plan.”
Is this you?
This engagement fits if
What You Get
Deliverables
Data Asset Inventory & Commercial Review
A structured catalog of every data asset you hold (claims, ADT feeds, patient-reported outcomes, clinical outcomes, biometrics) with history depth, cadence, consent language, and usage restrictions mapped against commercial potential.
Buyer & Use-Case Segmentation
A clear map of who actually pays for data like yours (pharma HEOR, payer analytics, CROs and trial sponsors, health tech) and which of your assets each buyer values, ranked by speed to revenue.
Facilitated Strategy Session
A full-day working session with your leadership team. Competing ideas get pressure-tested in the room, and the group leaves with one agreed direction instead of five open debates.
Near-Term Revenue Plan
The fastest credible path to data revenue, often clinical trial patient identification or risk-scoring built on data you already have, with the pre-work, owners, and sequencing to start immediately.
Long-Term Data Asset Roadmap
How the near-term work compounds into a durable asset: de-identification readiness, data organization against real buyer criteria, and the partnerships required to sell responsibly.
Strategy Summary & Recommendations
A written summary of decisions, recommended actions, owners, and risks: the document your board and team can execute against, delivered within days of the session.
After We're Done
Expected Outcomes
- One agreed data priority instead of competing internal initiatives
- A sequenced roadmap where near-term revenue work builds the long-term asset
- Clear view of consent, permissions, and compliance constraints before anything is sold
- Defined buyer segments with realistic expectations on pricing and timelines
- Data-readiness requirements your engineering team can actually execute
- Stakeholder alignment: everyone leaves the room with the same plan
How It Runs
The process
- 01
Pre-work: Inventory
Assets catalogued with depth, cadence, consent language, and restrictions. Prior inbound interest gathered. This happens before the session so the session can be about decisions.
- 02
Buyer mapping
Who pays for data like yours, which assets each buyer values, and what each one screens for, ranked by realistic speed to revenue.
- 03
Facilitated session
A full day with your leadership team where the competing paths get pressure-tested and the priority call gets made in the room.
- 04
Roadmap and summary
The written strategy summary with decisions, owners, sequencing, and risks, delivered within days while the session is still fresh.
Where You Are
Commonly a fit at these stages
Each stage page covers the situation in more detail, including what changes and which engagements tend to fit.
Related Reading
All posts
The 5 Types of Data Your Business Is Already Collecting That Companies Will Pay For
Discover the 5 commercially valuable data types your small business already collects and learn how to turn them into a real recurring revenue stream.
Your Data Isn't Too Niche - That's Exactly Why It's Valuable
Small businesses have data that large enterprises desperately want. Here's why your niche dataset is your next revenue stream.
How Health Tech Companies Actually Monetize Their Data
Most data monetization efforts die in a conference room, not in the market. The sequencing that works: one near-term play that builds the long-term asset.
FAQ
Common questions
What is a data monetization strategy engagement?
+
It's a focused engagement built around a facilitated working session with your leadership team. Before the session, we inventory your data assets, permissions, and prior interest. In the session, we pressure-test commercial paths (clinical trials support, de-identified real-world data, internal data products) and make the priority calls together. You leave with a written strategy summary and a sequenced roadmap.
Who is this for?
+
Health tech companies, value-based care organizations, digital health platforms, and any data-rich business sitting on proprietary data (claims, clinical, patient-reported, or device data) without an agreed plan to turn it into revenue. It's especially useful when multiple stakeholders have competing ideas and no one owns the decision.
Do we need to share patient data or sign a BAA?
+
No. The engagement works at the strategy level: what assets exist, their volume, cadence, consent language, and restrictions, not record-level data. No PHI changes hands, so a BAA typically isn't required.
We don't know what our data is worth. Is that a problem?
+
That's usually the reason to run the session. Most teams undervalue depth and overvalue breadth. Recurring, validated, longitudinal data on an engaged population is difficult to replicate and commands real value, but only when it's organized against what buyers actually screen for. The session establishes what you have, who pays for it, and what it takes to get there.
How does clinical trials support fit into data monetization?
+
Trial support is often the fastest revenue path: sponsors and CROs consistently struggle to fill trials, and a pre-screened, engaged patient population is exactly what they pay for. Better still, organizing your data around trial inclusion and exclusion criteria is the same work that matures your data into a saleable real-world data asset. One effort, sequenced correctly, serves both goals.
What happens after the session?
+
You receive the strategy summary and recommendations within days, with owners and sequencing proposed for each next step. Many teams execute independently from there; others continue with follow-on advisory or a fractional engagement to drive the roadmap. Both are optional. The deliverable stands on its own.
More on how engagements are scoped, priced, and run on the full FAQ.
Also Consider
Related engagements
Audit + 6–12 Month Roadmap
AI & Workflow Modernization Audit
A structured read on what AI can genuinely do in your context, and a phased plan your engineers can build.
Learn more1–2 Days / Week
Fractional CPO
Embedded product leadership one to two days a week, accountable to outcomes rather than to a deliverable.
Learn more8-Week Engagement
Product Strategy Sprint
A focused eight weeks that ends in a prioritized twelve-month roadmap your team can execute.
Learn moreReady to get started?
Book a free 30-minute call. We'll talk through your situation and confirm whether this engagement is the right fit.